Merck
CN
  • Phosphoserine aminoacylation of tRNA bearing an unnatural base anticodon.

Phosphoserine aminoacylation of tRNA bearing an unnatural base anticodon.

Biochemical and biophysical research communications (2008-05-28)
Ryuya Fukunaga, Yoko Harada, Ichiro Hirao, Shigeyuki Yokoyama
ABSTRACT

An unnatural base pair between 7-(2-thienyl)-imidazo[4,5-b]pyridine (Ds) and pyrrole-2-carbaldehyde (Pa) could expand the genetic alphabet and allow the incorporation of non-standard amino acids into proteins at defined positions. For this purpose, we synthesized tRNAs bearing Pa at the anticodon and tested non-standard amino acid phosphoserine aminoacylation by the wild-type and various engineered phosphoseryl-tRNA synthetases (SepRSs). The D418N D420N T423V triple mutant of SepRS efficiently charged phosphoserine to tRNA containing the PaUA anticodon with a K(m)=47.1muM and a k(cat)=0.151s(-1), which are comparable to the values of the wild-type SepRS for its cognate substrate, tRNA(Cys) with the GCA anticodon (26.9muM and 0.111s(-1)). The triple mutant SepRS and the tRNA with the PaUA anticodon represent a specific pair for the site-specific incorporation of phosphoserine into proteins in response to the UADs codon within mRNA.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pyrrole-2-carboxaldehyde, 98%